15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
17
Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors.
Genkyotex
63
First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.
Genkyotex
12
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor.
Sapienza University of Rome
71
Targeting NOX2 with Bivalent Small-Molecule p47phox-p22phox Inhibitors.
University of Copenhagen
24
Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease.
Korea University
17
Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors.
University of Pittsburgh
2
The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health.
Msd The Francis Crick Institute
23
COMPOUND ACTIVE AS INHIBITOR OF COLONY STIMULATION FACTOR-1 RECEPTOR (CSF-1R)
Norwegian University of Science and Technology
8
BICYCLIC HETEROCYCLIC FGFR4 INHIBITOR, PHARMACEUTICAL COMPOSITION AND PREPARATION COMPRISING SAME, AND APPLICATION THEREOF
Hangzhou Apeloa Medicine Research Institute Co.
4
Inhibitors of protein tyrosine phosphatases
Indiana University Research and Technology